In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.The discovery of this relationship can be traced back to ...
Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.
The Hong Kong company saw a reduction in body weight across both cohorts with no serious adverse events reported.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback